J. Carroll

J.
Martin Carroll is currently Lead Director at Catalent Pharma Solutions, Inc. since 2021.
Former positions include Chairman at Esperion Therapeutics, Inc. from 2022 to 2026, Chairman at Inotek Pharmaceuticals Corp.
from 2016 to 2018, Independent Director at Keenova Therapeutics Plc from 2013 to 2022, Independent Director at TherapeuticsMD, Inc. from 2015 to 2021, Independent Director at Catalent, Inc. from 2023 to 2024, Director at Boehringer Ingelheim Corp.
from 2011 to 2012, Director at Durata Therapeutics, Inc. in 2014, Director at Accredo Health, Inc. from 2004 to 2005, Director at Pharmaceutical Research & Manufacturers of America, Independent Director at VIVUS, Inc. from 2013 to 2014, President & Chief Executive Officer at Boehringer Ingelheim Pharmaceuticals, Inc. from 2003 to 2011, Global Head-Strategy & Development at Boehringer Ingelheim GmbH from 2012 to 2013, and Executive VP-Customer Marketing & Sales at Merck & Co., Inc. from 1976 to 2001.
Education includes an MBA from Babson College and undergraduate studies at Holy Cross College (Indiana).